Suggestions
Geetha Manjunath
Founder and CEO of Niramai Health Analytix
Geetha Manjunath is the Founder, CEO, and CTO of NIRAMAI Health Analytix, a startup developing an innovative non-invasive breast cancer screening solution using artificial intelligence.12 She has over 25 years of experience in IT research and has made significant contributions to the field through patents, publications, and new products.1
Education and Professional Background
Dr. Manjunath holds impressive academic credentials:
- PhD in Computer Science from the Indian Institute of Science (IISc)12
- Master's Degree in Engineering from IISc, where she was a gold medalist1
- Management education from Kellogg's School of Management at Northwestern University2
Her professional journey includes:
- Lab Director of Data Analytics at Xerox Research Centre India2
- Principal Research Scientist and Research Manager at Hewlett-Packard Laboratories2
- Chief Lab Architect and Master Technologist at Hewlett-Packard Laboratories2
- Member Technical Staff and Project Lead at CDAC, where she contributed to developing India's first supercomputer2
Achievements and Recognition
Dr. Manjunath has received several accolades for her work:
- Winner of the 2009 NASCCOM IT Innovator award12
- Recipient of the 2010 MIT TR Grand Challenges award1
- Winner of the 2018 BIRAC WinER Award1
- IEEE Senior Member and former Chair of IEEE Computer Society, Bangalore Chapter12
She holds 14 US patents and has many more pending.1
NIRAMAI Health Analytix
At NIRAMAI, Dr. Manjunath leads the development of a low-cost, portable, non-contact, non-invasive, and radiation-free solution for detecting early-stage breast cancer in women of all age groups and breast densities.1 The company's mission is to address the global challenge of breast cancer detection, particularly in developing countries where affordability and accessibility are significant issues.1
Geetha Manjunath's work at NIRAMAI combines her expertise in artificial intelligence with her passion for improving healthcare, particularly in the area of breast cancer screening and early detection.
